Factor XIII inhibitor
Description
Ac-(D)-Asp-MA-Nle-Nle-Leu-Pro-Trp-Pro-OH is a site specific irreversible inhibitor of plasma trans-glutaminase (factor XIII, FXIII). Peptidic inhibitor containing an electrophilic Michael acceptor (MA) warhead.
The inhibitor shows 30-fold selectivity for FXIII compared to tissue transglutaminase:
IC50= 100 nM
(FXIII, using fluorescent Assay Substance A101)(1)
IC50= 3000 nM
(TG2, using fluorescent Assay Substance A101)(1)
Molecular Formula: C53H77N9O14
Chemical Structure:
![938758_ADG575](/uploads/artikeldetails/938758_adg575.jpg)
Molecular Weight: 1064.23
Purity by HPLC: >95 % (214 nm)
Presentation
5 mg off pale yellow solid powder
Solubility
3.50 mg/ml (3.28 mM) in PBS buffer.
Alternative 10μM in 0.1% (v/v) DMSO / aqueous buffers.
Pre-dissolve e.g. 2.15 mg (2.02 μmol) in 202 μl DMSO -dilute e.g. 10 μl of that stock solution (10mM) with 9990 μl aqueous buffer to obtain a 10 μM solution. DMSO stock solutions can be stored at -20°C for at least 6 months. To avoid too many freeze-thaw cycles, we strongly recommend storage of aliquots.
Storage
Store at -20°C, desiccate
Category: Research use only
Type: Inhibitor
Product Availability: Worldwide
Manufacturer: ImmBioMed GmbH & Co KG, Germany
For more information please click .pdf icon below.
Factor XIII inhibitor
Cat.No. ADG575
Article no.: 938758
Unit: 5 mg
Code: ADG575
Manufacturer: ImmBioMed GmbH & Co. KG
References
- A highly sensitive fluorometric assay for deter-mination of human coagulation factor XIII in plasma. Oertel K et al. Anal Biochem. 2007 Aug 15;367(2):152-158.
- Structure of active coagulation factor XIII triggered by calcium binding: basis for the design of next-generation anticoagulants. Stieler M et al. Angew Chem Int Ed Engl. 2013 Nov 4;52(45):11930-4.